Recombinant Mouse Reprimo-like protein (Rprml)

What is Reprimo-like protein (Rprml) and how does it relate to the Reprimo gene family?

Rprml belongs to the Reprimo gene family, which comprises single-exon genes with poorly understood physiological functions. While Reprimo (RPRM) has been characterized as a p53-dependent tumor suppressor functioning at the G2/M cell cycle checkpoint, Rprml has not yet had a firmly established role in physiology or pathology. The gene family's expression pattern shows conservation between zebrafish and human species, suggesting evolutionary importance . Unlike many genes, Rprml is intronless and expressed at very low levels in most tissues according to the Genotype-Tissue Expression (GTEx) database .

What are the known biological functions of Rprml in development?

Research using zebrafish models has revealed that Rprml plays an essential role in hematovascular development during embryonic stages. While the formation of hemangioblasts and the primitive wave of hematopoiesis occur normally in the absence of rprml, the loss of rprml leads to impaired definitive hematopoiesis. Specifically, there is a significant reduction in erythroid-myeloid precursors (EMP) at the posterior blood island (PBI) and a decline in definitive hematopoietic stem/progenitor cells (HSPCs) . Additionally, loss of rprml increases caspase-3 activity in endothelial cells within the caudal hematopoietic tissue (CHT), which serves as the first perivascular niche where HSPCs reside during zebrafish embryonic development .

What experimental approaches are most effective for studying Rprml function in mouse models?

When studying Rprml in mouse models, researchers should consider both genetic manipulation techniques and careful experimental design principles. For genetic manipulation, CRISPR-Cas9 has been effectively used to disrupt rprml expression in animal models . Antisense morpholino oligonucleotides have also proven useful for knockdown studies .

For experimental design, researchers should follow established principles that promote reproducibility. The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) guidelines provide a framework for ethical and reproducible animal research . Careful selection from available mouse strains is crucial, as phenotypic variability can occur despite genetic identity within a strain. Additionally, researchers must consider that mice are biological entities sensitive to environmental factors and continue to change developmentally over time .

What are the challenges in detecting and measuring Rprml expression in tissue samples?

Detecting Rprml presents significant challenges due to its naturally low expression levels in most tissues. For protein detection, immunohistochemical (IHC) staining has been successfully employed, though results typically show weak to moderate cytoplasmic expression even in normal tissues . When analyzing Rprml expression, researchers should employ semi-quantitative scoring systems. For example, in gastric tissue studies, median RPRML IHC scores were 1.5 (interquartile range: 1.0–1.5) in non-tumor adjacent mucosa compared to 0.5 (IQR: 0.1–1.0) in tumor tissues .

For transcript detection, techniques sensitive to low expression levels such as quantitative RT-PCR following treatment with demethylating agents may be necessary to overcome epigenetic silencing . RNA-seq data analysis requires careful normalization and comparison, as demonstrated in analyses of The Cancer Genome Atlas datasets that confirmed downregulation of RPRML mRNA in gastric tumor tissues .

How can recombinant Rprml be effectively produced for functional studies?

While the search results don't specifically detail production methods for recombinant Rprml, standard approaches for single-exon genes would apply. Since Rprml lacks introns, direct amplification from genomic DNA or cDNA can be performed for cloning into expression vectors. For functional studies, successful approaches have included stable transfection of GFP-tagged RPRML in cell lines that lack endogenous expression . Expression can be confirmed through fluorescence microscopy and Western blotting, with subsequent functional assays including colony formation, soft agar, MTS, and Ki67 immunofluorescence assays .

What evidence supports the tumor suppressor role of Rprml?

Multiple lines of experimental evidence support Rprml's tumor suppressor function. In vitro studies have demonstrated that RPRML overexpression significantly reduces clonogenic capacity, anchorage-independent growth, and cell proliferation . Specifically, cells with ectopic RPRML expression show decreased proliferation at 24h, 48h, and 72h after seeding as measured by MTS assay, and reduced expression of the proliferation marker Ki67 compared to both wild type and control GFP-expressing cells .

How does Rprml expression correlate with clinical outcomes in cancer models?

In gastric cancer studies, RPRML expression levels correlate significantly with patient outcomes, particularly in advanced disease stages. The following table summarizes key findings regarding RPRML expression and clinical outcomes:

When patients with advanced gastric cancer (Stage III-IV) were stratified into high and low RPRML expression groups, dramatic differences in survival rates were observed. The 2-year survival rates were 40.0% vs. 81.3%, and 5-year survival rates were 17.0% vs. 53.5% for low-expression vs. high-expression groups, respectively . This indicates that RPRML expression has prognostic value, particularly in advanced disease stages.

What is the potential of Rprml methylation as a biomarker in disease detection?

Circulating methylated RPRML DNA has demonstrated potential as a non-invasive biomarker for detecting diseases such as gastric cancer. Using a MethyLight assay covering 10 CpGs from a 142-bp target region near the transcription start site, studies have quantified methylated RPRML DNA in plasma samples . ROC curve analysis yielded an area under the curve (AUC) of 0.726 (95% CI: 0.583–0.869, p = 0.006) .

At an optimal cut-off point of 1.0 copy/mL plasma, the detection sensitivity for gastric cancer was 56.0% (95% CI: 34.93–75.60) with a specificity of 88.0% (95% CI: 68.78–97.45). The positive likelihood ratio was 4.67 (95% CI: 1.53–14.26) and the odds ratio was 9.34 (95% CI: 2.20–39.46, p = 0.002) . These metrics suggest that while methylated RPRML DNA alone may not achieve sufficient sensitivity for screening purposes, it could contribute to multi-biomarker panels without adding significant false positives.

How can researchers address phenotypic variability in mouse models when studying Rprml?

When working with mouse models to study Rprml, researchers must account for phenotypic variability even within genetically identical strains. This variability can confound experimental results if not properly addressed. Key strategies include:

• Statistical power calculations to determine appropriate sample sizes that account for expected variability

• Randomization of animals to experimental groups

• Blinding of researchers during data collection and analysis

• Careful control of environmental factors that might influence phenotype

• Inclusion of appropriate control groups matched for age, sex, and housing conditions

Additionally, researchers should report all relevant experimental conditions, including housing, diet, and handling procedures, to enhance reproducibility across different laboratories .

What are the recommended methods for detecting Rprml protein localization in tissue samples?

For detecting Rprml protein localization in tissue samples, immunohistochemistry (IHC) has been successfully employed. In gastric tissues, RPRML protein shows weak to moderate cytoplasmic expression in glandular and foveolar epithelial cells of normal mucosa . For quantification, semi-quantitative scoring systems have been used, with scores typically ranging from 0 to 3.

For more precise localization studies, immunofluorescence techniques can be used, as demonstrated with Ki67 and RPRML co-staining in proliferation studies . When working with recombinant tagged versions of the protein (such as GFP-tagged RPRML), fluorescence microscopy provides direct visualization of protein localization . Western blotting serves as a complementary approach to confirm expression levels and protein size.

How can researchers distinguish between the effects of Rprml and other Reprimo family members?

Distinguishing between Rprml and other Reprimo family members requires careful experimental design and specific analytical approaches:

• Use gene-specific targeting with CRISPR-Cas9 or antisense morpholino oligonucleotides that are designed to minimize off-target effects on related family members

• Employ rescue experiments with specific recombinant proteins to confirm phenotypic effects

• Utilize specific antibodies validated for selectivity against other family members

• Design RT-PCR primers that target unique regions of each family member's sequence

• Perform comparative expression analyses across tissues and developmental stages to identify differential expression patterns

While Reprimo (RPRM) and Reprimo-like (RPRML) share functional similarities as tumor suppressors, their tissue-specific expression patterns and regulation may differ, providing additional means of discrimination .

How should researchers interpret conflicting data regarding Rprml expression patterns across different tissues?

When encountering conflicting data about Rprml expression patterns, researchers should consider several factors:

• Tissue-specific regulation mechanisms, as Rprml is expressed at varying levels across different tissues

• Developmental timing, as expression may change throughout embryonic and adult stages

• Epigenetic regulation through DNA methylation, which can vary by tissue type and physiological state

• Sensitivity limitations of different detection methods, particularly given Rprml's naturally low expression levels

• Species differences, though expression patterns show conservation between some species like zebrafish and humans

Researchers should validate findings using multiple detection methods (e.g., both RNA and protein detection) and consider using 5-azacytidine treatment to unmask expression that may be silenced by methylation .

What considerations are important when analyzing the impact of Rprml knockout or overexpression?

When analyzing the impact of Rprml manipulation, researchers should consider:

• The model system context – effects may differ between in vitro cell lines, zebrafish models, and mouse models

• Compensatory mechanisms – other Reprimo family members may partially compensate for Rprml loss

• Developmental timing – effects of manipulation may vary based on when Rprml function is altered

• Tissue specificity – impacts may be more pronounced in tissues where Rprml normally plays a crucial role

• Assessment of multiple endpoints – examine both molecular (e.g., cell cycle) and phenotypic (e.g., hematopoiesis) outcomes

For knockout studies, both complete gene knockout and conditional approaches should be considered, as the former may reveal developmental roles while the latter can help distinguish between developmental and homeostatic functions in adult tissues.

How can researchers effectively compare Rprml functions across different species models?

Cross-species comparison of Rprml functions requires careful consideration of evolutionary conservation and divergence:

• Sequence homology analysis to determine conservation of key functional domains

• Expression pattern comparison across equivalent developmental stages and tissues

• Functional testing in multiple species using comparable methodologies

• Creation of humanized mouse models expressing human RPRML when appropriate

• Complementation studies to determine functional equivalence across species

The conservation of RPRML expression patterns between zebrafish and humans suggests functional conservation , but researchers should still validate findings across species. When studying disease relevance, consider species-specific differences in disease susceptibility and progression that might influence the interpretation of Rprml's role.